Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago M de Carvalho

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|February 9, 2026
Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverageTiago M de Carvalho, Johannes Berkhof, Johannes A Bogaards
The Prostate|April 19, 2017
When should active surveillance for prostate cancer stop if no progression is detected?Tiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
International Journal of Cancer|December 24, 2015
Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) menTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
International Journal of Cancer|August 16, 2014
Screening for prostate cancer in the US? Reduce the harms and keep the benefitTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
BJU International|May 26, 2016
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation studyTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
Cancer|December 13, 2017
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillanceTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 11, 2019
Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using EmulatorsTiago M de Carvalho, Eveline A M Heijnsdijk, Luc Coffeng, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 8, 2021
Choosing a Metamodel of a Simulation Model for Uncertainty QuantificationTiago M de Carvalho, Joost van Rosmalen, Harold B Wolff, et al.
Cancer|April 25, 2017
Is prostate cancer different in black men? Answers from 3 natural history modelsAlex Tsodikov, Roman Gulati, Tiago M de Carvalho, et al.
The Lancet. Oncology|September 29, 2022
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling studyIrene Man, Damien Georges, Tiago M de Carvalho, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|February 9, 2026
Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverageTiago M de Carvalho, Johannes Berkhof, Johannes A Bogaards
The Prostate|April 19, 2017
When should active surveillance for prostate cancer stop if no progression is detected?Tiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
International Journal of Cancer|December 24, 2015
Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) menTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
International Journal of Cancer|August 16, 2014
Screening for prostate cancer in the US? Reduce the harms and keep the benefitTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
BJU International|May 26, 2016
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation studyTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
Cancer|December 13, 2017
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillanceTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 11, 2019
Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using EmulatorsTiago M de Carvalho, Eveline A M Heijnsdijk, Luc Coffeng, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 8, 2021
Choosing a Metamodel of a Simulation Model for Uncertainty QuantificationTiago M de Carvalho, Joost van Rosmalen, Harold B Wolff, et al.
Cancer|April 25, 2017
Is prostate cancer different in black men? Answers from 3 natural history modelsAlex Tsodikov, Roman Gulati, Tiago M de Carvalho, et al.
The Lancet. Oncology|September 29, 2022
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling studyIrene Man, Damien Georges, Tiago M de Carvalho, et al.
Pageof 2